entinostat has been researched along with Cancer, Radiation-Induced in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cutaneous squamous cell carcinomas are a common form of highly mutated keratinocyte skin cancers that are of particular concern in immunocompromised patients." | 1.51 | Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model. ( Cole, PA; Dinkova-Kostova, AT; Eroglu, A; Fahey, JW; Holtzclaw, WD; Kalin, JH; Leigh, I; Liu, H; Proby, CM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalin, JH | 1 |
| Eroglu, A | 1 |
| Liu, H | 1 |
| Holtzclaw, WD | 1 |
| Leigh, I | 1 |
| Proby, CM | 1 |
| Fahey, JW | 1 |
| Cole, PA | 1 |
| Dinkova-Kostova, AT | 1 |
1 other study available for entinostat and Cancer, Radiation-Induced
| Article | Year |
|---|---|
Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.
Topics: Administration, Topical; Animals; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proli | 2019 |